ADDING MULTIMEDIA Abiomed Receives FDA Approval of The AbioCor(R), the World's First Completely Self-Contained, (RedNova)
-- Conference Call Scheduled for September 5, 2006 at 3 PM Eastern Abiomed, Inc. (NASDAQ: ABMD) announced today it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration (FDA) for its AbioCor(R) Implantable Replacement Heart (AbioCor).

FDA approves limited use of artificial heart (News-Medical-Net)
The Food and Drug Administration (FDA) in the United States has given approval for limited use of an artificial heart.

King Pharma acquires Avinza from Ligand (PharmaBiz)
King Pharmaceuticals, Inc. has entered into a definitive asset purchase agreement and related agreements with Ligand Pharmaceuticals Incorporated to acquire rights to Avinza (morphine sulfate extended release).